By Michael Fahy,
From Crain's Manchester Business
Advanced Medical Solutions, the wound care firm based in Winsford, has announced that it has gained approval from the US Food and Drug Administration for the use of its newly-developed silver PU anti-bacterial foam dressings.
The dressing has been developed by combining silver, which is widely recognised as a safe and effective anti-microbial agent, with foam from Corpura - a company in which AMS acquired a 49.4 percent stake in May 2008. It said that foam is one of the largest and fastest growing segments of the $3200 million advanced woundcare market and is "an ideal material for the treatment of medium-to-high exudate chronic wounds."
The product has gained approval for use in treating pressure sores, diabetic ulcers, leg ulcers, graft and donor sites, lacerations and abrasions, first and second degree burns, trauma wounds and post-operative surgical wounds.
The firm said it was now working to find a suitable partner who can help to sell the product in the states. It added that European approval is likely to take longer and the full commercial benefit of the product will only be realised once it has both.
AMS's chief executive officer Dr Don Evans said that the approval "extends the AMS portfolio of materials incorporating silver and underlines the benefits of our acquisition last year of an interest in Corpura".
"This approval marks the first success of an innovative development programme to combine actives into Corpura's polyurethane foam technology and we look forward to further progress from this programme."
Following the announcements, its shares climbed by 5 per cent to 29.75p.
"
